文献速递肝病

基于机器学习的模型用于诊断合并肝脂肪变的慢性乙型肝炎患者的进展期纤维化与肝硬化

Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-06-19

本研究利用机器学习为合并肝脂肪变的初治慢性乙型肝炎患者构建进展期纤维化和肝硬化无创诊断模型。随机森林模型在训练队列中诊断进展期纤维化的AUROC为0.778(95%CI 0.749-0.807),诊断肝硬化为0.777(95%CI 0.748-0.806),并在验证队列中保持较高AUROC。该模型在训练队列中优于FIB-4、NFS和APRI。

要点

  • 随机森林模型诊断进展期纤维化AUROC 0.778(95%CI 0.749-0.807)。
  • 随机森林模型诊断肝硬化AUROC 0.777(95%CI 0.748-0.806)。
  • 两个模型在训练队列中优于FIB-4、NFS和APRI,验证队列表现良好。

核心结论

  • 随机森林模型为合并肝脂肪变的慢性乙型肝炎患者提供了可靠的进展期纤维化和肝硬化无创识别工具。

研究设计与样本

  • 研究纳入10个医疗中心接受肝活检的初治合并肝脂肪变的慢性乙型肝炎患者,分为训练队列和独立外部验证队列(NCT05766449)。
  • 共纳入1198例符合条件的患者,实施6种机器学习模型预测进展期纤维化和肝硬化,最终模型基于SHAP(Shapley Additive exPlanations)衍生。

主要发现

  • 训练队列中,随机森林进展期纤维化模型诊断进展期纤维化的AUROC为0.778(95%CI 0.749-0.807),随机森林肝硬化模型诊断肝硬化的AUROC为0.777(95%CI 0.748-0.806)。
  • 验证队列中两个模型保持较高AUROC。
  • 训练队列中,随机森林进展期纤维化模型在HBV DNA≥10^5 IU/mL患者中的AUROC为0.825(95%CI 0.787-0.862),随机森林肝硬化模型在女性患者中的AUROC为0.828(95%CI 0.774-0.883)。
  • 训练队列中两个模型优于FIB-4、NFS和APRI,验证队列中表现亦良好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The global rise of chronic hepatitis B (CHB) superimposed on hepatic steatosis (HS) warrants noninvasive, precise tools for assessing fibrosis progression. This study leveraged machine learning (ML) to develop diagnostic models for advanced fibrosis and cirrhosis in this patient population. METHODS: Treatment-naive CHB patients with concurrent HS who underwent liver biopsy in 10 medical centers were enrolled as a training cohort and an independent external validation cohort (NCT05766449). Six ML models were implemented to predict advanced fibrosis and cirrhosis. The final models, derived from SHAP (Shapley Additive exPlanations), were compared with Fibrosis-4 Index, nonalcoholic fatty liver disease Fibrosis Score, and aspartate aminotransferase-to-platelet ratio index using the area under receiver-operating characteristic curve (AUROC) and decision curve analysis (DCA). RESULTS: Of 1,198 eligible patients, the random forest model achieved AUROCs of 0.778 (95% confidence interval [CI], 0.749-0.807) for diagnosing advanced fibrosis (random forest advanced fibrosis model) and 0.777 (95% CI, 0.748-0.806) for diagnosing cirrhosis (random forest cirrhosis model) in the training cohort, and maintained high AUROCs in the validation cohort. In the training cohort, the random forest advanced fibrosis model obtained an AUROC of 0.825 (95% CI, 0.787-0.862) in patients with hepatitis B virus DNA ≥105 IU/mL, and the random forest cirrhosis model had an AUROC of 0.828 (95% CI, 0.774-0.883) in female patients. The 2 models outperformed Fibrosis-4 Index, nonalcoholic fatty liver disease Fibrosis Score, and aspartate aminotransferase-to-platelet ratio index in the training cohort, and also performed well in the validation cohort. CONCLUSIONS: The random forest models provide reliable, noninvasive tools for identifying advanced fibrosis and cirrhosis in CHB patients with concurrent HS, offering a significant advancement in the comanagement of the 2 diseases. CLINICALTRIALS: gov, Number: NCT05766449.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Rui F, Xu L, Yeo YH, et al. Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis. Clin Gastroenterol Hepatol. 2024. PMID: 38906440. doi:10.1016/j.cgh.2024.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。